Animal model of posthypoxic myoclonus: Effects of serotonergic antagonists

Neurology

Volumn 52, Issue 1, 1999, Pages 16-21

  Pappert, Eric J ^a,b   Goetz, C G ^a   Vu, T Q ^a   Ling, Z D ^a   Leurgans, S ^a   Raman, R ^a   Carvey, P M ^a  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 FLUORO 2 METHOXY 1H INDOLE 3 CARBOXYLIC ACID 1 [2 (METHYLSULFONAMIDO)ETHYL] 4 PIPERIDINYLMETHYL ESTER; EPLIVANSERIN; MESULERGINE; METITEPINE; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; ONDANSETRON; RECEPTOR SUBTYPE; SEROTONIN 1 RECEPTOR; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN HYPOXIA; CONTROLLED STUDY; DOSE RESPONSE; HEART ARREST; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MYOCLONUS; NONHUMAN; PRIORITY JOURNAL; RAT; RESUSCITATION; SEROTONINERGIC SYSTEM;

EID: 0032953598     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.1.16     Document Type: Article

References (26)

1. Lance JW, Adams RD. The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy. Brain 1963; 86:111-136.
2. Fahn S. Posthypoxic action myoclonus: review of the literature and report of two new cases with response to valproate and estrogen. Adv Neurol 1979;26:49-105.
3. Guilleminault C, Tharp BR, Cousin D. HVA and 5-HIAA CSF measurements and 5-HTP trials in some patients with involuntary movements. J Neurol Sci 1973;18:435-441.
4. Van Woert MH, Rosenbaum D. L-5-hydroxytryptophan therapy in myoclonus. Adv Neurol 1979;26:107-115.
5. Chadwick D, Hallett M, Harris R, Jenner P, Reynolds EH, Marsden CD. Clinical, biochemical and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam. Brain 1977;100:455-487.
6. Thai LJ, Sharpless NS, Wolfson L, Katzman R. Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations. Ann Neurol 1980;7:570-576.
7. Lhermitte F, Marteau R, Degos CF. Analyse pharmacologique d'un nouveau cas de myoclonies d'intention et d'action postanoxiques. Rev Neurol (Paris) 1972;126:107-114.
8. Pranzatelli MR. Effect of chronic treatment with 5-hydroxytryptophan on cortical serotonin receptors in the rat. Clin Neuropharmacol 1988;11:257-262.
9. Stewart RM, Growdon JH, Cancian D, Baldessarini RJ. Myoclonus after 5-hydroxytryptophan in rats with lesions of indoleamine neurons in the central nervous system. Neurology 1974;26:690-692.
10. Castaigne P, Cambier J, Escourolle R, Cathala HP, Lacasble R. Observation anatomo-clinique d'un syndrome myoclonique post-anoxique. Rev Neurol (Paris) 1964;111:60-73.
11. Kawai K, Nitecka L, Ruetzler CA, et al. Global cerebral ischemia associated with cardiac arrest in the rat: I. Dynamics of early neuronal changes. J Cereb Blood Flow Metab 1992;12: 238-249.
12. Matsumoto RR, Aziz N, Truong DD. Association between brain indole levels and severity of posthypoxic myoclonus in rats. Pharmacol Biochem Behav 1995;50:533-538.
13. Kanthasamy AG, Vu TQ, Truong DD. Neurochemical and behavioral correlates of posthypoxic myoclonus: a microdialysis study. Neurosci Abstr 1995;21:2058. Abstract.
14. 1A receptors in vivo. Eur J Pharmacol 1993;240:307-310.
15. 1C/2 receptor agonists and antagonists. Eur J Pharmacol 1993;244:1-5.
16. 1C receptor subtype. Neurosci Lett 1989;105:174-176.
17. 1D receptor antagonist, on brain 5-HT metabolism, extracellular 5-HT concentration and behaviour in the guinea pig. Neuropharmacology 1995;34:383-392.
18. 2 receptor antagonist. J Pharmacol Exp Ther 1992;262:759-768.
19. Costall B, Jones BJ, Kelly ME, et al. The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam. Pharmacol Biochem Behav 1989;34:769-778.
20. Letty S, Child R, Dumuis A, Pantaloni A, Bockaert J, Rondouin G. 5-HT4 receptors improve social olfactory memory in the rat. Neuropharmacology 1997;36:681-687.
21. Truong DD, Galloway MP, Pezzoli G, Jamrozik Z, Fahn S. Milacemide increases 5-hydroxytryptamine and dopamine levels in rat brain - possible mechanisms of milacemide antimyoclonic property in the p,p′-DDT-induced myoclonus. Pharmacol Biochem Behav 1989;32:993-1001.
22. Truong DD, Matsumoto RR, Schwartz PH, Hussong MJ, Wasterlain CG. Novel rat cardiac arrest model of posthypoxic myoclonus. Mov Disord 1994;9:201-206.
23. Schwartz PH, Matsumoto RR, Hussong MJ, Nguyen C, Vo P, Truong DD. Behavioral, physiological and pharmacological aspects of stimulus-induced postanoxic myoclonus in the rat. Soc Neurosci Abstr 1992;18:661.9. Abstract.
24. Fleshler M. Adequate acoustic stimulus for startle reaction in the rat. J Comp Physiol Psychol 1965;60:200-207.
25. Matsumoto RR, Hussoung MJ, Truong DD. Effects of selective serotonergic ligands on posthypoxic audiogenic myoclonus. Mov Disord 1995;10:615-621.
26. 1/2 receptor subtypes. Eur J Pharmacol 1998;347:51-56.